CTLA4 and melanoma: To this end, a landmark study examined the immunologic effects of SBRT, anti-CTLA-4 and anti-PD-1 in mouse models of melanoma and pancreatic cancer, and found that radiation plays a non-redundant role in combination with CTLA-4 and PD-1 blockade [41].